Not a Patent or a 'Printed Publication'? Not a Problem—IPR Prior Art Not Limited to § 102(a)

August 8, 2023

Reading Time : 2 min

In a Final Written Decision, the Patent Trial and Appeal Board has held that prior art under 35 U.S.C. § 102(e) was available in an inter partes review proceeding. The patent at issue was directed to alternating current driven LEDs, LED circuits and AC drive circuits and methods. The Petitioner challenged the claims under § 103(a), relying on a prior art reference (“Martin”) in seven of the nine grounds. Martin described LEDs formed on a single substrate connected in series for use with an AC source.

The Patent Owner argued that Martin was unavailable as prior art because it was neither a patent nor a printed publication as of the priority date of the challenged patent. The Patent Owner further argued that the Petitioner had cited no authority for invoking Martin’s filing date as its effective prior art date under § 102(e). According to the Petitioner, the reference qualified as prior art—despite publishing after the priority date—because it was a patent application filed in the United States before the challenged patent’s priority date. The Board agreed with Petitioner.

First, the Board contrasted the statute governing the formerly available covered business method proceeding with the statute governing IPRs. In CBM proceedings, the statute explicitly limited challenges to those based on prior art under § 102(a). But the language of the statute governing IPRs, § 311(b), imposes no such limitation.

Next, the Board noted that none of the cases the parties cited squarely addressed the issue. Still, the Federal Circuit has applied § 102(e) prior art in an appeal from an IPR. And the Board has also instituted trials and found claims unpatentable based on § 102(e) prior art. Because the Martin reference was filed in the United States before the challenged patent’s filing date, the Board found that Martin was available as a prior art reference in this IPR proceeding. As such, the Board found all the challenged claims unpatentable under § 103(a) in view of Martin and other prior art references.

Practice Tip: The AIA permits the use of § 102(e) prior art in IPR proceedings. Because the Board may institute trial on grounds that rely on § 102(e) prior art, Patent Owners are well advised to scrutinize substantively the suitability of such references when attempting to defeat IPR institution or an unpatentability finding in a final written decision.

Samsung Elecs. Co., Ltd. v. Lynk Labs, Inc., No. IPR2022-00149, Paper 33 (P.T.A.B. Jun. 26, 2023)

Share This Insight

Previous Entries

IP Newsflash

July 13, 2026

In a precedential and sua sponte Director Review decision, USPTO Director Squires recently vacated three related institution decisions nearly six months after institution where a district court later found the challenged claims invalid. Because the fourteen-day deadline to request Director Review of the institution decisions had passed, the Director used this opportunity to formally extend the deadline in two ways. First, he extended the fourteen-day deadline under 37 C.F.R. § 42.75(c)(1) to thirty days, which “puts requests for Director Review of decisions to institute trial on equal footing to requests for Director Review of final decisions or decisions not to institute trial.” Second, he outlined certain “exceptional circumstances” that warrant a further extension of the deadline to account for changes in the case that “surface after the deadline.” In the case at hand, the Director found the district court’s invalidity finding to be such an “exceptional circumstance” and ultimately initiated review and vacated the institution decisions on that basis.

...

Read More

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

IP Newsflash

April 9, 2026

In the April 1, 2026 edition of the Official Gazette, the U.S. Patent and Trademark Office announced a new procedural framework that permits patent owners to submit a limited, early response to a request for ex parte reexamination.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.